These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22490375)

  • 1. Ventricular oversensing of an implantable cardioverter-defibrillator during electroconvulsive therapy.
    Anguera I; Gálvez V; Sabaté X
    Europace; 2012 Oct; 14(10):1482. PubMed ID: 22490375
    [No Abstract]   [Full Text] [Related]  

  • 2. Electroconvulsive therapy in patients with cardiac pacemakers and implantable cardioverter defibrillators.
    Dolenc TJ; Barnes RD; Hayes DL; Rasmussen KG
    Pacing Clin Electrophysiol; 2004 Sep; 27(9):1257-63. PubMed ID: 15461716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic implantable cardioverter defibrillator in electroconvulsive therapy.
    Bryson EO; Popeo DM; Briggs MC; Pasculli RM; Kellner CH
    J ECT; 2015 Mar; 31(1):e22. PubMed ID: 25148111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rehospitalization rate after continued electroconvulsive therapy--a retrospective chart review of patients with severe depression.
    Nordenskjöld A; von Knorring L; Engström I
    Nord J Psychiatry; 2011 Feb; 65(1):26-31. PubMed ID: 20482461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
    Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
    J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroconvulsive therapy in the setting of implantable cardioverter-defibrillators.
    Davis A; Zisselman M; Simmons T; McCall WV; McCafferty J; Rosenquist PB
    J ECT; 2009 Sep; 25(3):198-201. PubMed ID: 19300291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patient with an implanted cardiac defibrillator not deactivated during acute and maintenance electroconvulsive therapy.
    Gálvez V; Anguera I; Soria V; Salvat-Pujol N; Sabaté X; Menchón JM; Urretavizcaya M
    Psychosomatics; 2012; 53(5):478-81. PubMed ID: 22445091
    [No Abstract]   [Full Text] [Related]  

  • 9. Maintenance electroconvulsive therapy: an alternative treatment for refractory schizophrenia and schizoaffective disorders.
    Lévy-Rueff M; Gourevitch R; Lôo H; Olié JP; Amado I
    Psychiatry Res; 2010 Feb; 175(3):280-3. PubMed ID: 20034675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ECT with implantable cardioverter defibrillator.
    Pornnoppadol C; Isenberg K
    J ECT; 1998 Jun; 14(2):124-6. PubMed ID: 9641812
    [No Abstract]   [Full Text] [Related]  

  • 11. Appropriateness for electroconvulsive therapy (ECT) can be assessed on a three-item scale.
    Kellner CH; Popeo DM; Pasculli RM; Briggs MC; Gamss S
    Med Hypotheses; 2012 Aug; 79(2):204-6. PubMed ID: 22595805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Predictors of outcome in electroconvulsive therapy.
    Enns MW
    Can J Psychiatry; 1999 Nov; 44(9):921-2. PubMed ID: 10584164
    [No Abstract]   [Full Text] [Related]  

  • 13. Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery.
    O'Neill JO; Starling RC; Khaykin Y; McCarthy PM; Young JB; Hail M; Albert NM; Smedira N; Chung MK
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1250-6. PubMed ID: 16256775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoiding inappropriate ventricular tachycardia detection due to T-wave oversensing in an implantable cardioverter defibrillator: a novel application of the electrogram width criterion.
    Duru F; Bauersfeld U; Candinas R
    Europace; 2001 Jan; 3(1):80-4. PubMed ID: 11271957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of left anterior right temporal electrode placement in electroconvulsive therapy: 3 case reports.
    Weiss AM; Hansen SM; Safranko I; Hughes P
    J ECT; 2015 Mar; 31(1):e1-3. PubMed ID: 24831996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The comparative studies of therapeutic results in patients with psychotic refractory depression treated with selected antidepressants and unilateral ECT].
    Hese RT; Gruszczyński W; Szwed A; Kielc M; Zalitacz M
    Psychiatr Pol; 2002; 36(6 Suppl):81-4. PubMed ID: 12647425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of T-wave oversensing with implantable cardioverter defibrillator generator replacement in an adolescent.
    Tuzcu V
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):929-32. PubMed ID: 17584279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting outcome after implantable cardioverter-defibrillator therapy: a new piece to the puzzle?
    Shepard RK; Ellenbogen KA
    J Am Coll Cardiol; 2009 Aug; 54(9):829-31. PubMed ID: 19695462
    [No Abstract]   [Full Text] [Related]  

  • 20. Living with life-saving technology - coping strategies in implantable cardioverter defibrillators recipients.
    Flemme I; Johansson I; Strömberg A
    J Clin Nurs; 2012 Feb; 21(3-4):311-21. PubMed ID: 21951323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.